U.S., Oct. 3 -- ClinicalTrials.gov registry received information related to the study (NCT07855458) titled 'ESA Hyporesponsiveness in Hemodialysis Patients' on Sept. 28.
Brief Summary: This prospective cohort study aims to evaluate the development, persistence, and recovery of erythropoiesis-stimulating agent (ESA) hyporesponsiveness among patients receiving maintenance hemodialysis.
Study Start Date: Oct. 02
Study Type: OBSERVATIONAL
Condition:
Chronic Kidney Disease (CKD)
Hemodialysis Complication
Anemia
Recruitment Status: NOT_YET_RECRUITING
Sponsor: Assiut University
Information provided by (Responsible Party): Hamid Ibrahim Hamid, Assiut University
Disclaimer: Curated by HT Syndication....